Computational modeling of apoptotic signaling pathways induced by cisplatin

BMC Systems Biology

Volumn 6, Issue , 2012, Pages

  Hong, Ji Young ^a   Kim, Geun Hong ^a   Kim, Jun Woo ^a   Kwon, Soon Sung ^a   Sato, Eisuke F ^b   Cho, Kwang Hyun ^c   Shim, Eun B ^a  

^a Kangwon National University   (South Korea)

^b SUZUKA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Apoptotic pathways; Cisplatin; Mathematical model

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; COMPUTER SIMULATION; DOSE RESPONSE; DRUG EFFECT; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TIME;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; MODELS, BIOLOGICAL; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY; TIME FACTORS;

EID: 84865983851     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-6-122     Document Type: Article

References (66)

1. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999, 340:1144-1153. 10.1056/NEJM199904153401502, 10202165.
2. Vokes EE, Weichselbaum RR, Mick R, McEvilly JM, Haraf DJ, Panje WR. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 1992, 84:877-882. 10.1093/jnci/84.11.877, 1375657.
3. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008, 73:994-1007. 10.1038/sj.ki.5002786, 18272962.
4. Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 2009, 61:223-242. 10.1016/j.etp.2008.09.003, 18986801.
5. Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci 2007, 334:115-124. 10.1097/MAJ.0b013e31812dfe1e, 17700201.
6. Servais H, Ortiz A, Devuyst O, Denamur S, Tulkens PM, Mingeot-Leclercq MP. Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. Apoptosis 2008, 13:11-32. 10.1007/s10495-007-0151-z, 17968659.
7. Lieberthal W, Triaca V, Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 1996, 270:F700-F708.
8. Servais H, Van Der Smissen P, Thirion G, Van der Essen G, Van Bambeke F, Tulkens PM, Mingeot-Leclercq MP. Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria. Toxicol Appl Pharmacol 2005, 206:321-333. 10.1016/j.taap.2004.11.024, 16039943.
9. Lee RH, Song JM, Park MY, Kang SK, Kim YK, Jung JS. Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem Pharmacol 2001, 62:1013-1023. 10.1016/S0006-2952(01)00748-1, 11597570.
10. Raffray M, Cohen GM. Apoptosis and necrosis in toxicology: a continuum or distinct modes of cell death?. Pharmacol Ther 1997, 75:153-177. 10.1016/S0163-7258(97)00037-5, 9504137.
11. Gordon JA, Gattone VH. Mitochondrial alterations in cisplatin-induced acute renal failure. Am J Physiol 1986, 250:F991-F998.
12. Mandic A, Hansson J, Linder S, Shoshan MC. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem 2003, 278:9100-9106. 10.1074/jbc.M210284200, 12509415.
13. Chauhan SS, Liang XJ, Su AW, Pai-Panandiker A, Shen DW, Hanover JA, Gottesman MM. Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines. Br J Cancer 2003, 88:1327-1334. 10.1038/sj.bjc.6600861, 2747565, 12698203.
14. Brune B. Nitric oxide and apoptosis in mesangial cells. Kidney Int 2002, 61:786-789. 10.1046/j.1523-1755.2002.00221.x, 11849426.
15. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999, 15:269-290. 10.1146/annurev.cellbio.15.1.269, 10611963.
16. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489. 10.1016/S0092-8674(00)80434-1, 9390557.
17. Chen M, Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis 2002, 7:313-319. 10.1023/A:1016167228059, 12101390.
18. Mayer B, Oberbauer R. Mitochondrial regulation of apoptosis. News Physiol Sci 2003, 18:89-94.
19. Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius S. Role of mitochondria in toxic oxidative stress. Mol Interv 2005, 5:94-111. 10.1124/mi.5.2.7, 15821158.
20. Lavrik IN, Eils R, Fricker N, Pforr C, Krammer PH. Understanding apoptosis by systems biology approaches. Mol Biosyst 2009, 5:1105-1111. 10.1039/b905129p, 19756299.
21. Kitamura M. Endoplasmic reticulum stress and unfolded protein response in renal pathophysiology: Janus faces. Am J Physiol Renal Physiol 2008, 295:F323-F334. 10.1152/ajprenal.00050.2008, 18367660.
22. Inagi R. Endoplasmic reticulum stress in the kidney as a novel mediator of kidney injury. Nephron Exp Nephrol 2009, 112:e1-e9. 10.1159/000210573, 19342868.
23. Fussenegger M, Bailey JE, Varner J. A mathematical model of caspase function in apoptosis. Nat Biotechnol 2000, 18:768-774. 10.1038/77589, 10888847.
24. Choi HS, Han S, Yokota H, Cho KH. Coupled positive feedbacks provoke slow induction plus fast switching in apoptosis. FEBS Lett 2007, 581:2684-2690. 10.1016/j.febslet.2007.05.016, 17532319.
25. Huber HJ, Rehm M, Plchut M, Dussmann H, Prehn JH. APOPTO-CELL-a simulation tool and interactive database for analyzing cellular susceptibility to apoptosis. Bioinformatics 2007, 23:648-650. 10.1093/bioinformatics/btl684, 17237051.
26. Legewie S, Bluthgen N, Herzel H. Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability. PLoS Comput Biol 2006, 2:e120. 10.1371/journal.pcbi.0020120, 1570177, 16978046.
27. Jordan P, Carmo-Fonseca M. Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci 2000, 57:1229-1235. 10.1007/PL00000762, 11028915.
28. Kartalou M, Essigmann JM. Recognition of cisplatin adducts by cellular proteins. Mutat Res 2001, 478:1-21. 10.1016/S0027-5107(01)00142-7, 11406166.
29. Tsuruya K, Tokumoto M, Ninomiya T, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Hirakata H, Iida M. Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways. Am J Physiol Renal Physiol 2003, 285:F208-F218.
30. Razzaque MS, Koji T, Kumatori A, Taguchi T. Cisplatin-induced apoptosis in human proximal tubular epithelial cells is associated with the activation of the Fas/Fas ligand system. Histochem Cell Biol 1999, 111:359-365. 10.1007/s004180050368, 10403114.
31. Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Kishihara K, Hirakata H, Iida M. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 2003, 63:72-82.
32. Seth R, Yang C, Kaushal V, Shah SV, Kaushal GP. p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury. J Biol Chem 2005, 280:31230-31239. 10.1074/jbc.M503305200, 15983031.
33. Pabla N, Huang S, Mi QS, Daniel R, Dong Z. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem 2008, 283:6572-6583. 10.1074/jbc.M707568200, 18162465.
34. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303:1010-1014. 10.1126/science.1092734, 14963330.
35. Kruidering M, Van de Water B, de Heer E, Mulder GJ, Nagelkerke JF. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther 1997, 280:638-649.
36. Nishikawa M, Nagatomi H, Nishijima M, Ohira G, Chang BJ, Sato E, Inoue M. Targeting superoxide dismutase to renal proximal tubule cells inhibits nephrotoxicity of cisplatin and increases the survival of cancer-bearing mice. Cancer Lett 2001, 171:133-138. 10.1016/S0304-3835(01)00591-2, 11520596.
37. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999, 341:233-249. 10.1042/0264-6021:3410233, 1220352, 10393078.
38. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998, 281:1309-1312.
39. Kim JS, He L, Lemasters JJ. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 2003, 304:463-470. 10.1016/S0006-291X(03)00618-1, 12729580.
40. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000, 6:513-519. 10.1038/74994, 10802706.
41. Mandic A, Viktorsson K, Strandberg L, Heiden T, Hansson J, Linder S, Shoshan MC. Calpain-mediated Bid cleavage and calpain-independent Bak modulation: two separate pathways in cisplatin-induced apoptosis. Mol Cell Biol 2002, 22:3003-3013. 10.1128/MCB.22.9.3003-3013.2002, 133754, 11940658.
42. Nakagawa T, Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol 2000, 150:887-894. 10.1083/jcb.150.4.887, 2175271, 10953012.
43. Boyce M, Yuan J. Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 2006, 13:363-373. 10.1038/sj.cdd.4401817, 16397583.
44. Qian W, Nishikawa M, Haque AM, Hirose M, Masimo M, Sato E, Inoue M. Mitochondrial density determines the cellular sensitivity to cisplatin-induced cell death. Am J Physiol 2005, 289:C1466-C1475.
45. Hara K, Kasahara E, Takahashi N, Konishi M, Inoue J, Jikumaru M, Kudo S, Okamura H, Sato E, Inoue M. Mitochondria determine the efficacy of anticancer agents that interact with DNA but not the cytoskeleton. J Pharmacol Exp Ther 2011, 337:838-845. 10.1124/jpet.111.179473, 21421738.
46. Wei Q, Dong G, Franklin J, Dong Z. The pathological role of Bax in cisplatin nephrotoxicity. Kidney Int 2007, 72:53-62. 10.1038/sj.ki.5002256, 17410096.
47. Kaushal GP, Kaushal V, Hong X, Shah SV. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int 2001, 60:1726-1736. 10.1046/j.1523-1755.2001.00026.x, 11703590.
48. Park MS, De Leon M, Devarajan P. Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 2002, 13:858-865.
49. Baek SM, Kwon CH, Kim JH, Woo JS, Jung JS, Kim YK. Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells. J Lab Clin Med 2003, 142:178-186. 10.1016/S0022-2143(03)00111-2, 14532906.
50. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397:441-446. 10.1038/17135, 9989411.
51. Daugas E, Nochy D, Ravagnan L, Loeffler M, Susin SA, Zamzami N, Kroemer G. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 2000, 476:118-123. 10.1016/S0014-5793(00)01731-2, 10913597.
52. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000, 403:98-103. 10.1038/47513, 10638761.
53. Zong WX, Li C, Hatzivassiliou G, Lindsten T, Yu QC, Yuan J, Thompson CB. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol 2003, 162:59-69. 10.1083/jcb.200302084, 2172724, 12847083.
54. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003, 4:552-565. 10.1038/nrm1150, 12838338.
55. Morishima N, Nakanishi K, Takenouchi H, Shibata T, Yasuhiko Y. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem 2002, 277:34287-34294. 10.1074/jbc.M204973200, 12097332.
56. Camano S, Lazaro A, Moreno-Gordaliza E, Torres AM, de Lucas C, Humanes B, Lazaro JA, Milagros Gomez-Gomez M, Bosca L, Tejedor A. Cilastatin attenuates cisplatin-induced proximal tubular cell damage. J Pharmacol Exp Ther 2010, 334:419-429. 10.1124/jpet.110.165779, 20435919.
57. Mukhopadhyay P, Horvath B, Zsengeller Z, Zielonka J, Tanchian G, Holovac E, Kechrid M, Patel V, Stillman IE, Parikh SM, Joseph J, Kalyanaraman B, Pacher P. Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radic Biol Med 2012, 52:497-506. 10.1016/j.freeradbiomed.2011.11.001, 22120494.
58. Hara K, Kasahara E, Takahashi N, Konishi M, Inoue J, Jikumaru M, Kubo S, Okamura H, Sato E, Inoue M. Mitochondria determine the efficacy of anticancer agents that interact with DNA but not the cytoskeleton. J Pharmacol Exp Ther 2011, 337:838-845. 10.1124/jpet.111.179473, 21421738.
59. Chang B, Nishikawa M, Sato E, Utsumi K, Inoue M. l-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine. Arch Biochem Biophys 2002, 405:55-64. 10.1016/S0003-9861(02)00342-9, 12176057.
60. Fischer U, Schulze-Osthoff K. New approaches and therapeutics targeting apoptosis in disease. Pharmacol Rev 2005, 57:187-215. 10.1124/pr.57.2.6, 15914467.
61. Zhang T, Brazhnik P, Tyson JJ. Computational analysis of dynamical responses to the intrinsic pathway of programmed cell death. Biophys J 2009, 97:415-434. 10.1016/j.bpj.2009.04.053, 2711321, 19619456.
62. Schlatter R, Schmich K, Avalos Vizcarra I, Scheurich P, Sauter T, Borner C, Ederer M, Merfort I, Sawodny O. ON/OFF and beyond-a Boolean model of apoptosis. PLoS Comput Biol 2009, 5:e1000595. 10.1371/journal.pcbi.1000595, 2781112, 20011108.
63. Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout GB, Bahar I. Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. Biophys J 2006, 90:1546-1559. 10.1529/biophysj.105.068122, 1367306, 16339882.
64. Toivonen HT, Meinander A, Asaoka T, Westerlund M, Pettersson F, Mikhailov A, Eriksson JE, Saxen H. Modeling reveals that dynamic regulation of c-FLIP levels determines cell-to-cell distribution of CD95-mediated apoptosis. J Biol Chem 2011, 286:18375-18382. 10.1074/jbc.M110.177097, 3099654, 21324892.
65. Bentele M, Lavrik I, Ulrich M, Stosser S, Heermann DW, Kalthoff H, Krammer PH, Eils R. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J Cell Biol 2004, 166:839-851. 10.1083/jcb.200404158, 2172102, 15364960.
66. Stucki JW, Simon HU. Mathematical modeling of the regulation of caspase-3 activation and degradation. J Theor Biol 2005, 234:123-131. 10.1016/j.jtbi.2004.11.011, 15721041.